# A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.

> **NCT05620940** · PHASE1 · RECRUITING · sponsor: **Inventage Lab., Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Opioid Dependence
- Alcohol Dependence
- Multiple Sclerosis

## Interventions

- **DRUG:** Vivitrol Injectable Product
- **DRUG:** IVL3004
- **DRUG:** IVL4002

## Key facts

- **NCT ID:** NCT05620940
- **Lead sponsor:** Inventage Lab., Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-11
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05620940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05620940, "A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05620940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*